Annual Report

Overview

The report describes FY24 expansion in patient access, ending the year with 140 million U.S. covered lives and 250,000 SOZO patient tests. Group revenue was $10.3 million, while SOZO Core Business revenue was $9.7 million. Its ESG section reports 67% female Board representation and 47% women in the workforce, while noting that ImpediMed is in the early stages of its ESG journey.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Publication date: 29 August 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services